LGALS3 and depressive symptom measurement: Patients suffering from depression associated with type 1 diabetes showed higher levels of plasma Galectin-3, which was not associated with other commonly measured variables in diabetic patients, suggesting that Galectin-3 could contribute to development of AD, cardiovascular complications or cause mortality in depressed persons [131].